Latest Insider Transactions at Neuro Pace Inc (NPCE)
This section provides a real-time view of insider transactions for Neuro Pace Inc (NPCE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NeuroPace Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NeuroPace Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 22
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,609
-0.71%
|
$344,526
$14.05 P/Share
|
|
Apr 19
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,253
-0.52%
|
$255,542
$14.02 P/Share
|
|
Apr 18
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,623
-0.07%
|
$36,722
$14.06 P/Share
|
|
Apr 17
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
300
-0.01%
|
$4,200
$14.15 P/Share
|
|
Apr 16
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,069
-0.4%
|
$196,966
$14.01 P/Share
|
|
Apr 12
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
23,101
-0.65%
|
$323,414
$14.42 P/Share
|
|
Apr 11
2024
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
461,899
-11.54%
|
$6,466,586
$14.49 P/Share
|
|
Mar 29
2024
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
1,799
+0.31%
|
$23,387
$13.2 P/Share
|
|
Mar 29
2024
|
Joseph Lacob |
BUY
Grant, award, or other acquisition
|
Direct |
852
+12.46%
|
$11,076
$13.2 P/Share
|
|
Mar 29
2024
|
Rakhi Kumar |
BUY
Grant, award, or other acquisition
|
Direct |
1,136
+13.2%
|
$14,768
$13.2 P/Share
|
|
Mar 29
2024
|
Uri Geiger |
BUY
Grant, award, or other acquisition
|
Direct |
899
+13.82%
|
$11,687
$13.2 P/Share
|
|
Mar 03
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,334
-2.14%
|
$20,010
$15.99 P/Share
|
|
Mar 03
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,042
-0.78%
|
$15,630
$15.99 P/Share
|
|
Feb 27
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+12.16%
|
-
|
|
Feb 27
2024
|
Joel Becker CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
52,470
+50.0%
|
-
|
|
Feb 27
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+7.59%
|
-
|
|
Feb 20
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
12,474
-16.62%
|
$212,058
$17.5 P/Share
|
|
Feb 20
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,832
-6.87%
|
$167,144
$17.5 P/Share
|
|
Feb 12
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+23.77%
|
$0
$0.03 P/Share
|
|
Feb 05
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,446
-4.24%
|
$51,690
$15.17 P/Share
|
|
Feb 02
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
14,143
-14.83%
|
$212,145
$15.07 P/Share
|
|
Feb 01
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
663
-0.69%
|
$9,945
$15.04 P/Share
|
|
Jan 31
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
52,810
+9.68%
|
$0
$0.03 P/Share
|
|
Jan 31
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,923
-1.96%
|
$28,845
$15.08 P/Share
|
|
Jan 30
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,262
-10.31%
|
$168,930
$15.1 P/Share
|
|
Jan 25
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1
-0.0%
|
$15
$15.0 P/Share
|
|
Jan 24
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
827
-0.75%
|
$12,405
$15.03 P/Share
|
|
Jan 22
2024
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
264
-0.35%
|
$3,696
$14.84 P/Share
|
|
Jan 22
2024
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.15%
|
$2,968
$14.84 P/Share
|
|
Dec 29
2023
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
2,303
+0.4%
|
$23,030
$10.31 P/Share
|
|
Dec 29
2023
|
Joseph Lacob |
BUY
Grant, award, or other acquisition
|
Direct |
1,091
+17.52%
|
$10,910
$10.31 P/Share
|
|
Dec 29
2023
|
Rakhi Kumar |
BUY
Grant, award, or other acquisition
|
Direct |
1,454
+18.67%
|
$14,540
$10.31 P/Share
|
|
Dec 29
2023
|
Uri Geiger |
BUY
Grant, award, or other acquisition
|
Direct |
1,151
+19.65%
|
$11,510
$10.31 P/Share
|
|
Dec 27
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
13,300
-10.78%
|
$133,000
$10.12 P/Share
|
|
Dec 26
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
102
-0.08%
|
$1,020
$10.0 P/Share
|
|
Dec 20
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,730
-2.16%
|
$27,300
$10.14 P/Share
|
|
Dec 06
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,005
-8.02%
|
$88,040
$8.16 P/Share
|
|
Dec 03
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,303
-1.7%
|
$10,424
$8.9 P/Share
|
|
Dec 03
2023
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,010
-0.7%
|
$8,080
$8.9 P/Share
|
|
Dec 01
2023
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
3,241
-0.06%
|
$25,928
$8.73 P/Share
|
|
Nov 30
2023
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,282
-0.13%
|
$58,256
$8.84 P/Share
|
|
Nov 29
2023
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,644
-0.1%
|
$45,152
$8.72 P/Share
|
|
Nov 28
2023
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
4,681
-0.08%
|
$37,448
$8.75 P/Share
|
|
Nov 27
2023
|
Kck Ltd. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
6,490
-0.12%
|
$51,920
$8.96 P/Share
|
|
Oct 22
2023
|
Martha Morrell CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
231
-0.3%
|
$1,386
$6.88 P/Share
|
|
Oct 22
2023
|
Rebecca Kuhn CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-0.12%
|
$1,074
$6.88 P/Share
|
|
Oct 03
2023
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
700
-0.02%
|
$6,300
$9.02 P/Share
|
|
Oct 02
2023
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,614
-0.19%
|
$68,526
$9.08 P/Share
|
|
Sep 29
2023
|
Frank M Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
2,440
+0.42%
|
$21,960
$9.73 P/Share
|
|
Sep 29
2023
|
Joseph Lacob |
BUY
Grant, award, or other acquisition
|
Direct |
1,156
+22.23%
|
$10,404
$9.73 P/Share
|